Marketers must make sure they’re clued up about what they can and can’t say when promoting their brand. Ellen Forrest-Charde, partner at Squire, Sanders & Dempsey LLP, examines the common pitfalls ...
Thirty telehealth firms received warning letters for illegal promotion of compounded semaglutide/tirzepatide, reflecting an expanded enforcement tempo that now surpasses the prior decade’s letter ...
Dr. Marty Makary, the FDA commissioner, on Tuesday announced plans to curb misleading pharmaceutical ads by enforcing regulations against drug manufacturers who hide or downplay warnings and side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results